Kaiyan Liu is the Molecular Pharmacology Highlighted Trainee Author for the July 2024 issue. Yabut is a research assistant in the Department of Urology, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.

The MolPharm article that earned him the selection as a Highlighted Trainee Author is titled “Mechanistic Understanding of Dexamethasone-Mediated Protection against Remdesivir-Induced Hepatotoxicity” and is available at https://doi.org/10.1124/molpharm.124.000894.

Liu hopes that her research will provide a deeper understanding of the mechanisms underlying Dexamethasone’s protective role against Remdesivir -induced liver toxicity, and that her work can inform the identification of more efficient targets to overcome liver toxicity induced by various compounds.